节点文献

1392例初诊儿童急性淋巴细胞白血病患者36种融合基因筛查分析

Analysis of 36 fusion genes in 1 392 patients of de novo pediatric acute lymphoblastic leukemia

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张建平杨君芳王芳房建成张阳朱平张英聂代静马小丽张羽王明宇张薇陈雪刘红星

【Author】 ZHANG Jianping;YANG Junfang;WANG Fang;FANG Jiancheng;ZHANG Yang;ZHU Ping;ZHANG Ying;NIE Daijing;MA Xiaoli;ZHANG Yu;WANG Mingyu;ZHANG Wei;CHEN Xue;LIU Hongxing;Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital;Department of Hematology,Hebei Yanda Lu Daopei Hospital;Department of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital;Department of Hematology, Peking University First Hospital;Beijing Lu Daopei Institute of Hematology;

【机构】 河北燕达陆道培医院造血干细胞移植科河北燕达陆道培医院血液科河北燕达陆道培医院病理和检验医学科北京大学第一医院血液科北京陆道培血液病研究院

【摘要】 目的:分析1 392例急性淋巴细胞白血病(acute lymphoblastic leukemia,ALL)患儿的36种融合基因情况。方法:回顾性分析2006年9月至2017年4月1 392例[1 185例急性B淋巴细胞白血病(B-cell acute lymphocyt ic leukemia,B-ALL)和207例急性T淋巴细胞白血病(T-cel l acute lymphocyt ic leukemia,T-ALL)]初诊儿童(≤14岁)ALL患者的36种融合基因筛查结果。采集初诊儿童ALL患者的骨髓或外周血标本,采用多重巢式PCR方法进行36种融合基因筛查。χ~2检验比较B-ALL和T-ALL之间融合基因阳性率差异。结果:1 392例患者中,411例(29.53%)检测到17种融合基因,其中2例(0.49%)同时携带2种融合基因。B-ALL患者中融合基因总阳性率显著高于T-ALL患者(31.73%vs 16.91%,P<0.001)。BCR-ABL1,E2A-PBX1和TEL-AML1基因型常见于B-ALL,而SILTAL1仅见于T-ALL。结论:各种融合基因在ALL中的阳性率及其在B-ALL和T-ALL中的分布特征,为进一步改进临床适用的融合基因检测方案提供数据基础。

【Abstract】 Objective: To analyze the gene-fusion landscape of 36 fusion genes in 1 392 patients(≤14 years) of de novo acute lymphoblastic leukemia(ALL). Methods: The results of 36 fusion gene screening tests were retrospectively analyzed in 1 392 cases [1 185 B-cell acute lymphocytic leukemia(B-ALL) and 207 T-cell acute lymphocyticleukemia(T-ALL)] from September 2006 to April 2017. Peripheral blood or bone marrow of childhood cases of de novo ALL were collected and total RNA were extracted. Fusion genes were assessed by multiplex-nested RT-PCR.Fisher’s exact test was performed to compare the incidences and frequencies of different fusion genes between B-ALL and T-ALL. Results: Of 1 392 patients, 17 types of fusion genes were detected in 411 patients(29.53%), and two of those cases(0.49%) with co-existence of two different fusion genes were identified. The incidence of fusion genes was statistically higher in B-ALL than in T-ALL patients(31.73% vs 16.91%, P<0.001). The incidences of BCR-ABL1, E2 APBX1 and TEL-AML1 were higher in B-ALL, while SIL-TAL1 was detected only in T-ALL patients. Conclusion: It will help to provide a data basis for further improvement of fusion gene screening panel in clinical applications.

  • 【文献出处】 临床与病理杂志 ,Journal of Clinical and Pathological Research , 编辑部邮箱 ,2018年05期
  • 【分类号】R733.71
  • 【被引频次】6
  • 【下载频次】185
节点文献中: 

本文链接的文献网络图示:

本文的引文网络